PRINCIPAL FINANCIAL GROUP INC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$64,000
-47.5%
10,535
-68.9%
0.00%
Q3 2019$122,000
+114.0%
33,821
+58.8%
0.00%
Q2 2019$57,000
-41.2%
21,297
-34.8%
0.00%
Q1 2019$97,000
+73.2%
32,659
-7.0%
0.00%
Q4 2018$56,000
-59.1%
35,102
-5.6%
0.00%
Q3 2018$137,000
+25.7%
37,165
-3.7%
0.00%
Q2 2018$109,000
-31.4%
38,600
-10.1%
0.00%
Q1 2018$159,000
+47.2%
42,928
+13.7%
0.00%
Q4 2017$108,000
+56.5%
37,771
+145.3%
0.00%
Q3 2017$69,000
-18.8%
15,396
-16.5%
0.00%
Q2 2017$85,000
-6.6%
18,449
-14.2%
0.00%
Q1 2017$91,000
+2.2%
21,5070.0%0.00%
Q4 2016$89,000
-48.0%
21,507
+2.0%
0.00%
Q3 2016$171,000
+5.6%
21,080
+1.2%
0.00%
Q2 2016$162,000
+1.9%
20,829
+1.2%
0.00%
Q1 2016$159,000
-27.7%
20,576
+0.7%
0.00%
Q4 2015$220,000
+60.6%
20,430
+2.7%
0.00%
Q3 2015$137,000
-23.9%
19,889
-1.9%
0.00%
Q2 2015$180,000
-6.7%
20,267
+3.4%
0.00%
Q1 2015$193,000
-6.3%
19,597
+16.4%
0.00%
Q4 2014$206,000
-3.7%
16,836
-21.6%
0.00%
Q3 2014$214,000
-78.9%
21,462
-93.6%
0.00%
-100.0%
Q3 2013$1,012,000
-76.7%
335,235
-36.9%
0.00%
-80.0%
Q2 2013$4,346,000531,2930.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders